Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022Kevin O’Laughlin, Max Veillard, Siobhán O’Connor et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 139
Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023Patricia Yu, Agam K. Rao, Riad Elmor et al.|NEJM Evidence|2024Cited by 39